CABA Cabaletta Bio Inc
Company Analysis
Latest News
🔴 Cabaletta Bio falls 5.2% — Biotech Sector Declines Amid Broad Market Rotation
With Biotech (XBI) down 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector, as represented by the XBI...
🔴 Cabaletta Bio is trading 5% down today with inflation-related pressure a possible factor
Cabaletta Bio is trading 5.25% lower at $1.53, with broader inflation-related pressure a possible factor. - No company-specific announcement explaining the...
🔴 Cabaletta Bio is trading 6.48% down in pre-market amid broader inflation-related market pressure
Cabaletta Bio is trading at $1.52, with a -6.48% change in pre-market; broader market pressure is a plausible factor. - No clear company-specific explanation...
🔴 Cabaletta Bio is trading 10.33% down today as hotter-than-forecast CPI pressures stocks
Cabaletta Bio is trading 10.33% lower at $1.52, with broad-market pressure providing context; no clear company-specific catalyst has been identified. -...
🔴 Cabaletta Bio is trading 5% down today amid broad-market pressure after hotter-than-forecast CPI
Cabaletta Bio is trading 5.1% down at $1.60, amid broader market pressure following September CPI above forecast. - September CPI was 3.7% year over year,...
🟢 Cabaletta Bio is trading 5.5% up in pre-market
Cabaletta Bio is trading 5.5% up at $1.78 in pre-market on October 14; the reason for the rebound remains unclear. - The stock closed at $1.69 on October 13. -...
🔴 Cabaletta Bio is trading 10% down today
Cabaletta Bio is trading 10.06% down at $1.61, with no clear company-specific catalyst identified for the October 13 decline. - The company’s latest release...
🔴 Cabaletta Bio is trading 5.9% down — no clear company-specific catalyst identified
Cabaletta Bio is trading at $1.69, down 5.87%, with no clear company-specific catalyst identified for the October 13 drop. - Shares were down from the October...
🟢 Cabaletta Bio is trading 5% up in pre-market with no confirmed catalyst
Cabaletta Bio is trading 5.03% up in pre-market at $1.88, compared with the October 12 close of $1.79; no confirmed company-specific announcement explains the...
🔴 Cabaletta Bio is trading 5% down
Cabaletta Bio is trading at $1.82, down 5.44%, with no confirmed company-specific catalyst identified. - No confirmed October 12 company announcement was...
🔴 Cabaletta Bio is trading 5% down today amid biotech sector weakness
Cabaletta Bio is trading down 5.29% now at $1.97, amid broad weakness in clinical-stage biotech stocks. - The XBI is down 2.50%; major U.S. indexes are higher,...
🟢 Cabaletta Bio is trading 5% up today amid broader market gains
Cabaletta Bio is trading 5.25% higher at $2.10 on October 5, 2026, with broader market strength the clearest available context for the gain. - The S&P 500 was...
🟢 Cabaletta Bio is trading 6% up today as payrolls eased Fed rate-hike concerns
Cabaletta Bio is trading up 6.08% at $2.00 on October 2, 2026, in line with a broader risk-on session. - U.S. stocks rallied after September payrolls came in...
🔴 Cabaletta Bio is trading 5.6% down today as Treasury yields hit a 19-year high
Cabaletta Bio is trading 5.6% down at $2.10 as a surge in Treasury yields and oil prices intensified risk-off selling on September 24, 2026. - The 10-year...
🔴 Cabaletta Bio is trading 10.2% down today as oil and Treasury yields revive inflation concerns
Cabaletta Bio is trading at $2.25 (-10.20%) as higher crude oil prices and Treasury yields revive inflation concerns, pressuring risk assets and biotechnology...
🔴 Cabaletta Bio is trading 5.52% down today as broader markets weaken
Cabaletta Bio is trading at $2.36, down 5.52%, after opening-session weakness on September 23, 2026, amid broader market pressure. - The Nasdaq is down 1.10%...
🟢 Cabaletta Bio is trading 5% up in pre-market amid major U.S. indices rising more than 0.5%
Cabaletta Bio is trading at $2.68 (+5.10%) in pre-market amid broader risk-on sentiment. - No new company-specific announcement dated September 21, 2026 was...
🟢 Cabaletta Bio is trading 8.29% up in after-hours trading; no clear company-specific announcement identified
Cabaletta Bio is trading 8.29% up at $2.70 after closing at $2.49 on September 16, 2026; no clear company-specific announcement explaining the after-hours move...
🔴 Cabaletta Bio is trading 10.1% down today amid sector-led biotech weakness
Cabaletta Bio is trading at $2.62, declining -10.14% alongside weaker biotech sentiment and a 2.11% drop in the XBI biotech ETF. - The move follows...
🔴 Cabaletta Bio falls 5.3% — Biotech Sector Declines on Key Drug Trial Failure and Shifting Investor Sentiment
With Biotech (XBI) down 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, as measured by the XBI ETF, fell...